Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,503 | 7,098 | 8,614 | 6,817 | 7,442 |
| Receivables | 14,500 | 14,572 | 16,043 | 12,109 | 11,937 |
| Inventories | 22,230 | 22,205 | 20,805 | 21,604 | 22,255 |
| Other current assets | 3,230 | 3,604 | 2,763 | 3,275 | 3,335 |
| TOTAL | $46,463 | $47,479 | $48,225 | $43,805 | $44,969 |
| Non-Current Assets | |||||
| PPE Net | 5,347 | 4,869 | 4,787 | 4,990 | 4,913 |
| Intangibles | 15,550 | 16,278 | 17,198 | 17,904 | 19,291 |
| Other Non-Current Assets | 8,926 | 9,312 | 9,861 | 11,293 | 10,920 |
| TOTAL | $29,823 | $30,459 | $31,846 | $34,187 | $35,124 |
| Total Assets | $76,286 | $77,938 | $80,071 | $77,992 | $80,093 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 33,967 | 34,864 |
| Accounts payable and accrued liabilities | 6,224 | 5,287 | 3,652 | 5,176 | 4,722 |
| Other current liabilities | 18,569 | 18,576 | 18,308 | 15,253 | 15,616 |
| TOTAL | $24,793 | $23,863 | $21,960 | $54,396 | $55,202 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,682 | 36,211 | 35,870 | N/A | N/A |
| Other Non-Current Liabilities | 7,082 | 7,505 | 8,190 | 8,795 | 8,424 |
| TOTAL | $44,075 | $44,029 | $44,377 | $9,528 | $9,158 |
| Total Liabilities | $68,868 | $67,892 | $66,337 | $63,924 | $64,360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,552 | 4,510 | 4,472 | 4,458 | 4,453 |
| Common Shares | 447 | 447 | 447 | 446 | 445 |
| Retained earnings | -221,044 | -218,134 | -214,710 | -211,863 | -210,632 |
| Other shareholders' equity | -12,375 | -12,313 | -11,672 | -12,437 | -11,702 |
| TOTAL | $7,418 | $10,046 | $13,734 | $14,068 | $15,733 |
| Total Liabilities And Equity | $76,286 | $77,938 | $80,071 | $77,992 | $80,093 |